| Common Name | BIIB 059, BIIB-059, BIIB059 |
|---|---|
| Synonyms | BDCA-2, CD303 |
| Applications | ELISA, Flow Cyt |
| Recommended Dilutions | ELISA 1:5000-10000, Flow Cyt 1:100 |
| Buffer | Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions. |
| Formulation & Reconstitution | Powder |
| Host Species | Humanized |
| IgG type | IgG1 |
| Reactivity | Human |
| Storage & Shipping | Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized proteins are shipped at ambient temperature. |
| Guarantee | 12 months from date of dispatch |
| Background | Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals. |
Anti-CLEC4C (litifilimab biosimilar) mAb
Price: 50μg $80.00 ; 100 μg $160.00
Product Data
Images
Figure 1. ELISA plate pre-coated by 2 μg/mL (100 μL/well) Human CLEC4C Protein, hFc Tag (PME100756) can bind Anti-CLEC4C (litifilimab biosimilar) mAb (BME100155) in a linear range of 0.64–80.00 ng/mL.
Figure 2. Flow cytometry analysis with 1 μg/mL Anti-CLEC4C (litifilimab biosimilar) mAb (BME100155) on Expi293 cells transfected with Human CLEC4C protein (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram).